Optimization of valsartan encapsulation in biodegradables polyesters using Box-Behnken design.

[1]  Pınar Terzioğlu,et al.  Application of Box-Behnken design for modeling of lead adsorption onto unmodified and NaCl-modified zeolite NaA obtained from biosilica. , 2017, Water science and technology : a journal of the International Association on Water Pollution Research.

[2]  F. Dahmoune,et al.  Full factorial design optimization of anti-inflammatory drug release by PCL-PEG-PCL microspheres. , 2016, Materials science & engineering. C, Materials for biological applications.

[3]  Han‐Gon Choi,et al.  Effects of Formulation Variables on the Particle Size and Drug Encapsulation of Imatinib-Loaded Solid Lipid Nanoparticles , 2016, AAPS PharmSciTech.

[4]  Rameshwar K. Deshmukh,et al.  The impact of preparation parameters on sustained release aceclofenac microspheres: A design of experiments , 2015 .

[5]  A. Mokhtari,et al.  Optimization of heavy metal removal from aqueous solutions by maghemite (γ-Fe2O3) nanoparticles using response surface methodology , 2014 .

[6]  S. Honary,et al.  Optimization of particle size and encapsulation efficiency of vancomycin nanoparticles by response surface methodology , 2014, Pharmaceutical development and technology.

[7]  Khodir Madani,et al.  Pistacia lentiscus leaves as a source of phenolic compounds: Microwave-assisted extraction optimized and compared with ultrasound-assisted and conventional solvent extraction , 2014 .

[8]  Satyendra Mishra,et al.  FORMULATION AND EVALUATION OF GLIPIZIDE LOADED NANOPARTICLES , 2013 .

[9]  V. Rives,et al.  Drug release from layered double hydroxides and from their polylactic acid (PLA) nanocomposites , 2013 .

[10]  S. Etcheverry,et al.  Computational study and spectroscopic investigations of antihypertensive drugs , 2012 .

[11]  S. Etcheverry,et al.  Dinuclear copper(II) complexes with valsartan. Synthesis, characterization and cytotoxicity. , 2012, Journal of inorganic biochemistry.

[12]  Han‐Gon Choi,et al.  Novel valsartan-loaded solid dispersion with enhanced bioavailability and no crystalline changes. , 2012, International journal of pharmaceutics.

[13]  M.Bharathi,et al.  Preparation and in vitro and in vivo characterization of valsartan loaded eudragit nanoparticles , 2012 .

[14]  R. Manavalan,et al.  Preparation and evaluation of sustained release loxoprofen loaded microspheres , 2011, Journal of basic and clinical pharmacy.

[15]  D. N. Kumar,et al.  Formulation and characterisation of valsartan proniosomes , 2011 .

[16]  Patil Sv,et al.  FORMULATION AND CHARACTERISTICS OF 5­FLUROURACIL MICROSPHERES BY SOLVENT EVAPORATION METHOD , 2011 .

[17]  S. Mandal,et al.  Valsartan Loaded Solid Lipid Nanoparticles: Development, Characterization, and In vitro and Ex vivo Evaluation , 2011 .

[18]  A. Husain,et al.  Pharmacological and Pharmaceutical Profile of Valsartan: A Review , 2011 .

[19]  D. Sakarkar,et al.  Spherically agglomerated solid dispersions of valsartan to improve solubility, dissolution rate and micromeritic properties , 2010 .

[20]  Hyo-Kyung Han,et al.  Improved pH-independent dissolution and oral absorption of valsartan via the preparation of solid dispersion , 2010, Archives of pharmacal research.

[21]  Han‐Gon Choi,et al.  Development of valsartan-loaded gelatin microcapsule without crystal change using hydroxypropylmethylcellulose as a stabilizer , 2010, Drug delivery.

[22]  R. Sinisterra,et al.  Pharmaceutical Composition of Valsartan: β-Cyclodextrin: Physico–Chemical and Characterization Anti-Hypertensive Evaluation , 2010, Molecules.

[23]  Kaan Yetilmezsoy,et al.  Response surface modeling of Pb(II) removal from aqueous solution by Pistacia vera L.: Box-Behnken experimental design. , 2009, Journal of hazardous materials.

[24]  S. Maiti,et al.  Investigation on Processing Variables for the Preparation of Fluconazole-Loaded Ethyl Cellulose Microspheres by Modified Multiple Emulsion Technique , 2009, AAPS PharmSciTech.

[25]  Kadam Vilasrao,et al.  Solid state characterization of the inclusion complex of valsartan with methyl β-cyclodextrin , 2009 .

[26]  J. Nedelec,et al.  Effects of process parameters on the properties of biocompatible ibuprofen-loaded microcapsules. , 2009, International journal of pharmaceutics.

[27]  P. Verma,et al.  Preparation and in vitro characterization of Valsartan solid dispersions using skimmed milk powder as carrier. , 2009 .

[28]  S. Lakshmanaprabu,et al.  Formulation and evaluation of sustained release microspheres of rosin containing aceclofenac , 2009 .

[29]  B. Ursekar,et al.  Design, optimization, preparation and evaluation of dispersion granules of valsartan and formulation into tablets. , 2009, Current drug delivery.

[30]  Hermínio C. de Sousa,et al.  Preparation and characterization of flurbiprofen-loaded poly(3-hydroxybutyrate-co-3-hydroxyvalerate) microspheres , 2008, Journal of microencapsulation.

[31]  A. Gupta,et al.  New emerging trends in synthetic biodegradable polymers – Polylactide: A critique , 2007 .

[32]  M. Paquot,et al.  Les polymères issus du végétal : matériaux à propriétés spécifiques pour des applications ciblées en industrie plastique , 2006 .

[33]  Hoo-Kyun Choi,et al.  The effects of surfactants on the dissolution profiles of poorly water-soluble acidic drugs. , 2006, International journal of pharmaceutics.

[34]  Yusuf Kaya,et al.  Response surface optimization of the removal of nickel from aqueous solution by cone biomass of Pinus sylvestris. , 2006, Bioresource technology.

[35]  A. Miro,et al.  Improvement of Solubility and Stability of Valsartan by Hydroxypropyl-\boldbeta-Cyclodextrin , 2006 .

[36]  Ranjana Gupta,et al.  PLGA Nanoparticles of Anti Tubercular Drug: Drug Loading and Release Studies of a Water In-Soluble Drug , 2003 .

[37]  D. Voinovich,et al.  Gemfibrozil encapsulation and release from microspheres and macromolecular conjugates. , 2002, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[38]  A. Lamprecht,et al.  The preparation and evaluation of poly(ϵ-caprolactone) microparticles containing both a lipophilic and a hydrophilic drug , 2000 .

[39]  J Gillard,et al.  Preparation and characterization of protein-loaded poly(epsilon-caprolactone) microparticles for oral vaccine delivery. , 1999, International journal of pharmaceutics.

[40]  C. Bastioli.  Biodegradable materials — Present situation and future perspectives , 1998 .

[41]  A. Coombes,et al.  Protein-loaded poly(dl-lactide-co-glycolide) microparticles for oral administration: formulation, structural and release characteristics , 1997 .

[42]  P. Sansdrap,et al.  Influence of manufacturing parameters on the size characteristics and the release profiles of nifedipine from poly(DL-lactide-co-glycolide) microspheres , 1993 .

[43]  김성종,et al.  Microencapsulation , 1974, Springer US.

[44]  S. Takka,et al.  BIOAVAILABILITY FILE: VALSARTAN , 2022 .